Evidence map›Paper›PMID 21522116›Full record

ReviewNature reviews. Gastroenterology & hepatology2011

Treatment and surveillance strategies in achalasia: an update.

Alexander J Eckardt, Volker F Eckardt

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01637311 naunknown statusnot on this map

Peroral Endoscopic Remyotomy for Failed Heller Myotomy

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2010 to 2014Enrolled20ConditionsEsophageal AchalasiaArmsPOEM
NCT01649843 naunknown statusnot on this map

Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2010 to 2014Enrolled450ConditionsEsophageal AchalasiaArmsPOEM
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Aflatoxin influences achalasia symptomatology.Molecular medicine reports · 2020
    Trial
  4. Trial
  5. Article
  6. Article
  7. Peroral endoscopic myotomy in spastic esophageal disorders: Clinical outcomes and optimal approaches.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Per-oral endoscopic dual myotomy for the treatment of achalasia.Esophagus : official journal of the Japan Esophageal Society · 2021
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexander J EckardtDepartment of Gastroenterology, Deutsche Klinik für Diagnostik, Aukammallee 33, 65191 Wiesbaden, Germany.
Volker F Eckardt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controversy exists with regard to the optimal treatment for achalasia and whether surveillance for early recognition of late complications is indicated. Currently, surgical myotomy and pneumatic dilation are the most effective treatments for patients with idiopathic achalasia, and a multicenter, randomized, international trial has confirmed similar efficacy of these treatments, at least in the short term. Clinical predictors of outcome, patient preferences and local expertise should be considered when making a decision on the most appropriate treatment option. Owing to a lack of long-term benefit, endoscopic botulinum toxin injection and medical therapies are reserved for patients of advanced age and those with clinically significant comorbidites. The value of new endoscopic, radiologic or surgical treatments, such as peroral endoscopic myotomy, esophageal stenting and robotic-assisted myotomy has not been fully established. Finally, long-term follow-up data in patients with achalasia support the notion that surveillance strategies might be beneficial after a disease duration of more than 10-15 years.

Indexed as

Digestive System Surgical ProceduresAnti-Dyskinesia AgentsBotulinum ToxinsEsophageal AchalasiaHumansTreatment OutcomeAnti-Dyskinesia AgentsBotulinum Toxins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.